The Relation of Serum Potassium Concentration with Cardiovascular Events and Mortality in Community-Living Individuals
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Background and objectives: Hyperkalemia is associated with adverse outcomes in patients with CKD and in hospitalized patients with acute medical conditions. Little is known regarding hyperkalemia, cardiovascular disease (CVD), and mortality in community-living populations. In a pooled analysis of two large observational cohorts, we investigated associations between serum potassium concentrations and CVD events and mortality, and whether potassium-altering medications and eGFR<60 ml/min per 1.73 m 2 modified these associations. Design, setting, participants, & measurements: Among 9651 individuals from the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS), who were free of CVD at baseline (2000–2002 in the MESA and 1989–1993 in the CHS), we investigated associations between serum potassium categories (<3.5, 3.5–3.9, 4.0–4.4, 4.5–4.9, and ≥5.0 mEq/L) and CVD events, mortality, and mortality subtypes (CVD versus non-CVD) using Cox proportional hazards models, adjusting for demographics, time-varying eGFR, traditional CVD risk factors, and use of potassium-altering medications. Results: Compared with serum potassium concentrations between 4.0 and 4.4 mEq/L, those with concentrations ≥5.0 mEq/L were at higher risk for all-cause mortality (hazard ratio, 1.41; 95% confidence interval, 1.12 to 1.76), CVD death (hazard ratio, 1.50; 95% confidence interval, 1.00 to 2.26), and non-CVD death (hazard ratio, 1.40; 95% confidence interval, 1.07 to 1.83) in fully adjusted models. Associations of serum potassium with these end points differed among diuretic users ( P interaction <0.02 for all), such that participants who had serum potassium ≥5.0 mEq/L and were concurrently using diuretics were at higher risk of each end point compared with those not using diuretics. Conclusions: Serum potassium concentration ≥5.0 mEq/L was associated with all-cause mortality, CVD death, and non-CVD death in community-living individuals; associations were stronger in diuretic users. Whether maintenance of potassium within the normal range may improve clinical outcomes requires future study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Serum potassium should also be monitored in individuals treated with diuretics because these medications can cause hypokalemia, which is associated with cardiovascular risk and mortality (38)(39)(40).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [38]
In the citing paper
“Serum potassium should also be monitored in individuals treated with diuretics because these medications can cause hypokalemia, which is associated with cardiovascular risk and mortality (38)(39)(40).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [38]
In the citing paper
“Restriction of dietary sodium (to <2,300 mg/day) may be useful to manage blood pressure and reduce cardiovascular risk (51,52), and individualization of potassium intake may be necessary to manage serum potassium concentrations (27,38,39).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [38]
In the citing paper
“Detection and management of these abnormalities is important because AKI and hyperkalemia each increase the risks of cardiovascular events and death (86).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [86]
In the citing paper
“Detection and management of these abnormalities is important because AKI and hyperkalemia each increase the risks of cardiovascular events and death (79).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [79]
Citations
Cites
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965 · cited 1×
“No adjustments were made for multiple comparisons, as our a priori hypothesis focused on these specific outcomes (19).”
BackgroundEstimating glomerular filtration rate from serum creatinine and cystatin C
Inker, L. A., Schmid, C. H., Tighiouart, H., Eckfeldt, J. H., Feldman, H. I., Greene, T., Kusek, J. W., Manzi, J., Van Lente, F., Zhang, Y. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114248 · Cited by 4,102
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942 · cited 4×
“Participants in the CHS were all aged $65 years at baseline and there was no exclusion for prevalent CVD (7,8).”
BackgroundMethodInfluentialFlexible smoothing with B-splines and penalties
Eilers, P. H. C., & Marx, B. D. (1996) · Statistical Science · doi:10.1214/ss/1038425655 · Cited by 3,666 · cited 1×
“To examine the functional form of fully adjusted associations between unit change in serum potassium concentration with each outcome, we used penalized smoothing splines with evenly spaced knots among the inner 95% distribution (18).”
MethodThe Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652 · cited 1×
“Participants in the CHS were all aged $65 years at baseline and there was no exclusion for prevalent CVD (7,8).”
BackgroundSelf-citationApplying Cox Regression to Competing Risks
Lunn, M., & McNeil, D. (1995) · Biometrics · doi:10.2307/2532940 · Cited by 975 · cited 1×
“With regard to cause-specific mortality, we utilized competing risks models as described by Lunn and McNeil (17).”
MethodThe Relationship of Left Ventricular Mass and Geometry to Incident Cardiovascular Events
Bluemke, D. A., Kronmal, R. A., Lima, J. A. C., Liu, K., Olson, J., Burke, G. L., & Folsom, A. R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.014 · Cited by 808 · cited 1×
“Total and CVD Mortality Total and CVD mortality were adjudicated by centralized events committees in both cohorts (11,12).”
MethodSurveillance and ascertainment of cardiovascular events
Ives, D. G., Fitzpatrick, A. L., Bild, D. E., Psaty, B. M., Kuller, L. H., Crowley, P. M., Cruise, R. G., & Theroux, S. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00093-9 · Cited by 688
Self-citationLaboratory methods and quality assurance in the Cardiovascular Health Study
Cushman, M., Cornell, E. S., Howard, P. R., Bovill, E. G., & Tracy, R. P. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.2.264 · Cited by 439 · cited 1×
“In the CHS, serum potassium was measured in 5132 samples from the 1989–1990 and 1992–1993 exams at the University of Vermont Laboratory for Clinical Biochemistry Research following standard procedures for collection and storage, and using the Kodak Ektachem 700 Analyzer (Eastman Kodak, Rochester, NY), a colorimetric m…”
MethodMeigs, J. B., Muller, D. C., Nathan, D. M., Blake, D. R., & Andres, R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1475 · Cited by 338
PSATY, B. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90143-b · Cited by 314
Self-citationSevere hyperkalemia requiring hospitalization: predictors of mortality
An, J. N., Lee, J. P., Jeon, H. J., Kim, D. H., Oh, Y. K., Kim, Y. S., & Lim, C. S. (2012) · Critical Care · doi:10.1186/cc11872 · Cited by 291 · cited 1×
“Although most individuals with hyperkalemic events concurrently have chronic or acute kidney disease, recent studies have suggested that patients admitted to the hospital with milder hyperkalemia and normal kidney function may also have a higher mortality risk (5).”
BackgroundLiao, F., Folsom, A. R., & Brancati, F. L. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70224-8 · Cited by 273 · cited 1×
“We did not have concurrent measurements of serum magnesium concentrations, which are known to influence serum potassium concentrations (23), and have previously been linked with mortality risk (24,25).”
BackgroundElectrocardiographic manifestations of hyperkalemia
Mattu, A., Brady, W. J., & Robinson, D. A. (2000) · The American Journal of Emergency Medicine · doi:10.1053/ajem.2000.7344 · Cited by 242
Potassium disorders—clinical spectrum and emergency management
Alfonzo, A. V. M., Isles, C., Geddes, C., & Deighan, C. (2006) · Resuscitation · doi:10.1016/j.resuscitation.2005.11.002 · Cited by 218 · cited 1×
“We did not have concurrent measurements of serum magnesium concentrations, which are known to influence serum potassium concentrations (23), and have previously been linked with mortality risk (24,25).”
BackgroundHyperkalemia, cardiac conduction, and the electrocardiogram: A review
Ettinger, P. O., Regan, T. J., & Oldewurtel, H. A. (1974) · American Heart Journal · doi:10.1016/0002-8703(74)90473-6 · Cited by 215
Magnesium and the Risk of Cardiovascular Events: A Meta-Analysis of Prospective Cohort Studies
Qu, X., Jin, F., Hao, Y., Li, H., Tang, T., Wang, H., Yan, W., & Dai, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057720 · Cited by 183 · cited 1×
“We did not have concurrent measurements of serum magnesium concentrations, which are known to influence serum potassium concentrations (23), and have previously been linked with mortality risk (24,25).”
BackgroundImportance of Potassium in Cardiovascular Disease
Sica, D. A., Struthers, A. D., Cushman, W. C., Wood, M., Banas, J. S., & Epstein, M. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.01728.x · Cited by 96 · cited 1×
“Although our data are observational, it may be reasonable to address other factors that influence serum potassium if found to be elevated in diuretic users (22).”
BackgroundHyperkalemia‐induced bundle branch block and complete heart block
Ohmae, M., & Rabkin, S. W. (1981) · Clinical Cardiology · doi:10.1002/clc.4960040110 · Cited by 34
Serum potassium and cardiovascular mortality
Fang, J., Madhavan, S., Cohen, H. W., & Alderman, M. H. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.91021.x · Cited by 30 · cited 2×
“4 mEq/L, were at higher risk of all-cause mortality (20).”
BackgroundFibrosis-Related Biomarkers and Risk of Total and Cause-Specific Mortality
Agarwal, I., Glazer, N. L., Barasch, E., Biggs, M. L., Djoussé, L., Fitzpatrick, A. L., Gottdiener, J. S., Ix, J. H., Kizer, J. R., Rimm, E. B., et al. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu067 · Cited by 28 · cited 1×
“, Parkinson disease, dementia, amyotrophic lateral sclerosis), or other, consistent with prior CHS manuscripts (13).”
BackgroundSelf-citationSevere hyperkalaemia: demographics and outcome
Phillips, B., Milner, S., Zouwail, S., Roberts, G. W., Cowan, M., Riley, S. G., & Phillips, A. O. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sft158 · Cited by 27 · cited 1×
“Research regarding hyperkalemia has focused almost exclusively on patients admitted to the hospital with acute medical conditions (6).”
BackgroundSerum Potassium and Risk of Cardiovascular Disease
Walsh, C. R., Larson, M. G., Leip, E. P., Vasan, R. S., & Levy, D. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.9.1007 · Cited by 24 · cited 1×
“In the Framingham Offspring Study, Walsh and colleagues (21) found no associations between serum potassium concentration and incident CVD events, CVD death, or all-cause mortality among 3151 participants followed for 16 years.”
BackgroundDeo, R., Katz, R., de Boer, I. H., Sotoodehnia, N., Kestenbaum, B. R., Mukamal, K. J., Chonchol, M., Sarnak, M. J., Siscovick, D. S., Shlipak, M. G., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.10.025 · Cited by 24
Self-citationEffects of Severe Hyperkalemia
Spodick, D. H. (2008) · The American Heart Hospital Journal · doi:10.1111/j.1751-7168.2008.07777.x · Cited by 16
Cited by
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s010 · Cited by 869
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s010 · Cited by 495
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s010 · Cited by 487
“Detection and management of these abnormalities is important because AKI and hyperkalemia each increase the risks of cardiovascular events and death (67).”
Background10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Das, S. R., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s010 · Cited by 486
9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s009 · Cited by 485
“Detection and management of these abnormalities is important because AKI and hyperkalemia each increase the risks of cardiovascular events and death (39).”
Background
Metadata
- Authors
- Hughes-Austin, J. M., Rifkin, D. E., Beben, T., Katz, R., Sarnak, M. J., Deo, R., Hoofnagle, A. N., Homma, S., Siscovick, D. S., Sotoodehnia, N., Psaty, B. M., de Boer, I. H., Kestenbaum, B., Shlipak, M. G., & Ix, J. H.
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-01-31
- Volume
- 12
- Issue
- 2
- Pages
- 245-252
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- PMC
- PMC5293337
- OpenAlex
- W2585143408
- Semantic Scholar
- b2fb70503ddc38b38f8e2fbfeae067172e33e713
- Cited by
- 92
- References
- 25
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 8 · 2022: 8 · 2021: 12 · 2020: 12 · 2019: 11 · 2018: 9 · 2017: 12
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc085079-024, n01hc085083-027, n01hc085080-026, n01hc095169-003, n01hc085086-022, n01hc55222-0-0-0, n01hc95159-40-0-1)
- National Institute on Aging (R01AG023629)
- National Heart, Lung, and Blood Institute (N01 HC085086, R01HL096875, N01-HC095169, N01 HC085079, N01 HC085083, N01 HC085080, HHSN 268200800007C, N01-HC-095159, K01HL122394, R01HL102214, HHSN268201200036C, N01HC085082, U01HL080295, N01 HC055222, N01 HC085081, R01HL080295)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK098234, K23DK091521)
- Topics
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- hyperkalemia, serum potassium, cardiovascular events, all-cause mortality, cardiovascular mortality, non-cardiovascular mortality, diuretics, estimated glomerular filtration rate, community-dwelling adults, Multi-Ethnic Study of Atherosclerosis, Cardiovascular Health Study, CKD-mineral and bone disorder, potassium-sparing diuretics
- MeSH terms
- Aged, Cardiovascular Diseases, Cause of Death, Diuretics, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Hyperkalemia, Male, Middle Aged, Potassium, United States, Independent Living, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.